TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›GNTX
GNTX logo

GNTX

GENTEX CORP

Next earnings Jul 23, 2026 (before open) · consensus $0.51 EPS, $680M rev

Last earnings +3.7% on 2026-04-24

Buy
$24.51
▼ -2.47%
$24.51▲ +13.74%
over 1Y
L $20.58H $28.63
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.5%
1W-4.9%
1M-0.5%
3M+14.6%
YTD+4.6%
1Y+13.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B
Valuation
Fair value
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 15 analysts
Buy

Near-debt-free auto-mirror leader outgrowing its end market with rising margins and big buybacks, at an undemanding 14.9x.

Revenue (FY2025) $2.53B · FY2025

The read

Solid fundamentals at a roughly fair price — reasonable risk/reward at today's level.

Gentex is the dominant supplier of auto-dimming rearview mirrors and a growing portfolio of connected-vehicle electronics (camera-based mirrors, dimmable aircraft windows, biometric and HomeLink technologies). FY2025 showed the company outgrowing a soft auto-production backdrop: revenue rose 9.6% to $2.53B and gross profit jumped 12.4% to $867M, lifting gross margin to 34.2% and operating income up 3.1% to $474M. Net income dipped 4.9% to $385M (EPS $1.74, essentially flat at -1.1%) — the divergence between rising operating income and slightly lower net income points to below-the-line items rather than operating weakness, while EPS held up thanks to buybacks.

The balance sheet is a key differentiator versus auto-parts peers: Gentex is effectively debt-free (only $3.80M short-term borrowings) with liabilities/equity of just 0.18x against $2.49B equity. That financial strength funds heavy reinvestment — R&D rose 12.0% to $203M (8% of sales), keeping the technology roadmap ahead of competitors — and aggressive capital returns. The company repurchased $315M of stock (up 53.1%, shrinking shares 5.2% to 215M) and paid $107M in dividends, all comfortably covered by $587M of operating cash flow (up 17.8%) against modest $129M capex. Cash did fall 37.6% to $146M as buybacks accelerated, but with no debt that is a capital-allocation choice, not stress.

Is GNTX a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread~90d expiry
  • Long call 24.5 @ ~1.43 est
  • Short call 27 @ ~0.53 est
debit $90max +$160max −$90BE 25.40

BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.73B$1.92B$2.30B$2.31B$2.53B
Gross profit$620M$610M$763M$771M$867M
Operating income$410M$370M$496M$460M$474M
Net income$361M$319M$428M$404M$385M
Diluted EPS$1.50$1.36$1.84$1.76$1.74
Net margin20.8%16.6%18.6%17.5%15.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.08B
EV / EBITDA8.8
EV / Sales2.0
EV / FCF11.1
P / FCF11.4
PEG (trailing)—
Earnings yield7.4%
FCF yield8.8%

Quality & risk

ROIC (est.)15.0%
Free cash flow$458M
Total debt$3.80M
Net cash$142M
Altman Z-Score9.56 safe
Piotroski F-Score7/9

Capital returns

Buyback yield6.0%
Dividend yield (est.)2.0%
Shareholder yield8.1%
Shares Δ YoY-5.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Shareholder vote2026-05-26
  2. 10-Q Quarterly report2026-05-06
  3. 8-K Earnings results2026-04-24
  4. DEF 14A Proxy statement2026-04-09
  5. 10-K Annual report2026-02-24
  6. 8-K Earnings results2026-01-30
  7. 10-Q Quarterly report2025-11-07
  8. 8-K Earnings results2025-10-24
  9. 10-Q Quarterly report2025-08-08

Recent filings

all on EDGAR ↗
S-8Filing2026-06-16open ↗SDFiling2026-05-28open ↗8-KPeriod ending 2026-05-212026-05-26open ↗4Period ending 2026-05-212026-05-22open ↗3Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB+
GrowthC-
ProfitabilityA-
Financial healthA
MomentumC-
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$20.92

Fairly valued -15% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.74 × (8.5 + 1.5 × 2.3% growth) × 1.00 quality = 12.0× multiple. An estimate, not a price target.

20.5852-week28.63
Revenue
$2.53B
+9.6% YoY
Net margin
15.2%
ROE
15.5%
P/E
14.1

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.53B+9.6%
Net income$385M-4.9%
Gross profit$867M+12.4%
Operating income$474M+3.1%
Diluted EPS$1.74-1.1%
Cash & equivalents$146M-37.6%
Total assets$2.93B+6.1%
Total liabilities$438M+51.6%
Stockholders' equity$2.49B+0.8%
Gross: 34.2%Op.: 18.7%L/E: 0.18x

Frequently asked

Is GENTEX CORP (GNTX) a buy?
GNTX currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Near-debt-free auto-mirror leader outgrowing its end market with rising margins and big buybacks, at an undemanding 14.9x.
What is GNTX's fair value?
A Modified-Graham model based on GNTX's SEC fundamentals estimates a fair value of about $20.92. It is an estimate from reported earnings, not a price target.
Is GNTX overvalued or undervalued?
Against a Modified-Graham fair-value estimate, GNTX currently appears fairly valued relative to its SEC-grounded earnings power.
What is GENTEX CORP's quality score?
GNTX scores 71.03985889549776/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000355811, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/21/2026, 8:56:12 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:56 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-21
KENNEDY JOHN C
Director
Award5.63K
2026-05-21
Zang Ling
Director
Award5.63K
2026-05-21
WALKER BRIAN C
Director
Award5.63K
2026-05-21
Starkoff Kathleen
Director
Award5.63K
2026-05-21
Schaum Richard O
Director
Award5.63K
2026-05-21
Pink Billy
Director
Award5.63K
2026-05-21
DEUR GARTH
Director
Award5.63K
2026-05-21
BROWN LESLIE L
Director
Award5.63K

Dividends

Quarterly
Yield (TTM)
2.4%
Annual / share
$0.60
Last ex-date
2026-07-08
Last amount
$0.12
ex 2026-07-08paid 2026-07-22$0.12
ex 2026-04-08paid 2026-04-22$0.12
ex 2026-01-07paid 2026-01-21$0.12
ex 2025-10-08paid 2025-10-22$0.12
ex 2025-07-09paid 2025-07-23$0.12
ex 2025-04-09paid 2025-04-23$0.12

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-24Beat +3.8% est▲ +4.97%8-K ↗
2026-01-30Beat +5.8% est▲ +1.83%8-K ↗
2025-10-24Miss -4.7% est▼ -9.11%8-K ↗
2025-07-25Beat +20.2% est▲ +11.95%8-K ↗
2025-04-25—▲ +2.35%8-K ↗
2025-01-31—▼ -11.27%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2019-01-23Greg GianforteSell$50.0K–$100KPTR ↗
2017-09-12Greg GianforteBuy$50.0K–$100KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score71 vs 67
Revenue growth9.6% vs 7.5%
Net margin15.2% vs 10.0%
Return on equity15.5% vs 12.0%
P/E14.1 vs 26.2